Profile data is unavailable for this security.
About the company
Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. The Company is focused on the design, development, and advancement of technology for better surgical treatment of spine disorders. The Company's Organic Innovation Machine is focused on developing new approaches that integrate with its expanding Alpha InformatiX (AIX) Platform to better inform surgery and safely and reproducibly achieve the goals of spine surgery. Its technologies include AIX, positioners, access systems, implants and fixation systems, and biologics. Its AIX product platform comprises its EOS imaging system and VEA alignment mobile application, its SafeOp Neural InformatiX System and its navigation-enabled robotics platform (Valence). It has developed approach-specific patient positioning systems that integrate with its other access systems, providing for a more rigid construct and enhanced reproducibility.
- Revenue in USD (TTM)728.02m
- Net income in USD-154.96m
- Incorporated2005
- Employees867.00
- LocationAlphatec Holdings Inc1950 Camino Via RobleCARLSBAD 92008United StatesUSA
- Phone+1 (760) 431-9286
- Fax+1 (302) 636-5454
- Websitehttps://atecspine.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kestra Medical Technologies Ltd | 74.26m | -138.79m | 1.56bn | 330.00 | -- | 8.40 | -- | 21.06 | -2.76 | -2.76 | 1.47 | 3.19 | 0.4034 | -- | 9.40 | 225,027.30 | -71.43 | -122.23 | -92.37 | -192.35 | 46.40 | -- | -177.06 | -342.51 | -- | -116.72 | 0.2033 | -- | 115.05 | -- | -25.08 | -- | 150.61 | -- |
| Procept Biorobotics Corp | 299.91m | -84.58m | 1.63bn | 756.00 | -- | 4.29 | -- | 5.44 | -1.54 | -1.54 | 5.45 | 6.81 | 0.6772 | 1.81 | 3.91 | 396,702.40 | -19.10 | -26.94 | -21.74 | -29.81 | 64.55 | 54.37 | -28.20 | -83.14 | 7.20 | -- | 0.1194 | -- | 64.84 | 105.21 | 13.68 | -- | -10.34 | -- |
| Omnicell Inc | 1.18bn | 2.05m | 1.64bn | 3.60k | 844.32 | 1.33 | 20.01 | 1.38 | 0.0432 | 0.0432 | 25.70 | 27.45 | 0.5786 | 7.19 | 5.01 | -- | 0.1002 | 0.7331 | 0.1357 | 0.9767 | 42.49 | 44.80 | 0.1732 | 1.32 | 1.22 | -- | 0.1198 | -- | 6.53 | 5.84 | -83.62 | -42.34 | 1.93 | -- |
| Pulse Biosciences Inc | 86.00k | -74.73m | 1.64bn | 75.00 | -- | 17.69 | -- | 19,077.36 | -1.14 | -1.14 | 0.0013 | 1.37 | 0.0009 | -- | -- | 1,146.67 | -74.06 | -83.75 | -80.63 | -94.40 | -224.42 | -- | -86,898.84 | -12,644.52 | 10.01 | -- | 0.00 | -- | -- | -- | -26.95 | -- | -27.12 | -- |
| AxoGen Inc | 214.71m | -2.10m | 1.70bn | 451.00 | -- | 12.95 | 350.47 | 7.92 | -0.0486 | -0.0486 | 4.56 | 2.62 | 1.05 | 1.55 | 7.75 | 476,073.20 | -1.03 | -11.36 | -1.17 | -13.05 | 74.76 | 78.42 | -0.9767 | -15.37 | 2.64 | 0.6493 | 0.2852 | -- | 17.81 | 11.91 | 54.12 | -- | -2.84 | -- |
| AtriCure Inc | 518.31m | -28.77m | 1.84bn | 1.30k | -- | 3.85 | -- | 3.54 | -0.608 | -0.608 | 10.90 | 9.59 | 0.829 | 1.68 | 8.79 | 398,696.20 | -4.60 | -3.84 | -5.24 | -4.25 | 74.87 | 74.53 | -5.55 | -7.13 | 2.85 | -17.96 | 0.1252 | -- | 16.55 | 15.05 | -46.85 | -- | 14.00 | -- |
| Artivion Inc | 422.65m | -9.12m | 1.88bn | 1.60k | -- | 4.28 | 135.44 | 4.44 | -0.242 | -0.242 | 9.48 | 9.26 | 0.509 | 1.72 | 5.16 | 264,153.80 | -1.10 | -2.47 | -1.29 | -2.66 | 64.50 | 65.02 | -2.16 | -5.89 | 2.88 | 1.29 | 0.3324 | -- | 9.75 | 7.06 | 56.37 | -- | 6.75 | -- |
| Inspire Medical Systems Inc | 882.62m | 44.56m | 1.93bn | 1.25k | 45.17 | 2.89 | 33.69 | 2.18 | 1.47 | 1.47 | 29.45 | 22.94 | 1.10 | 1.27 | 8.93 | 708,364.40 | 5.56 | -4.83 | 6.28 | -5.43 | 84.92 | 84.59 | 5.05 | -5.12 | 4.01 | -- | 0.00 | -- | 28.49 | 57.80 | 352.96 | -- | 70.20 | -- |
| LeMaitre Vascular Inc | 240.87m | 53.34m | 1.96bn | 651.00 | 37.92 | 5.18 | 30.86 | 8.15 | 2.28 | 2.28 | 10.35 | 16.71 | 0.494 | 1.03 | 7.45 | 369,993.80 | 10.94 | 9.09 | 11.69 | 9.89 | 70.97 | 66.24 | 22.14 | 16.64 | 11.45 | -- | 0.3077 | 38.38 | 13.63 | 13.40 | 46.28 | 19.68 | 13.11 | 15.91 |
| Quidelortho Corp | 2.71bn | -1.18bn | 1.99bn | 6.60k | -- | 0.9756 | -- | 0.7323 | -17.38 | -17.38 | 40.11 | 29.99 | 0.4351 | 2.41 | 7.18 | 411,272.70 | -18.91 | 0.0044 | -22.09 | 0.005 | 47.15 | 59.13 | -43.45 | 0.009 | 0.9805 | 0.6537 | 0.5663 | 0.00 | -7.17 | 39.07 | -20,216.83 | -- | 48.27 | -- |
| Alphatec Holdings Inc | 728.02m | -154.96m | 2.01bn | 867.00 | -- | 175.36 | -- | 2.76 | -1.05 | -1.05 | 4.91 | 0.2351 | 0.9497 | 1.28 | 7.90 | 839,700.10 | -20.21 | -27.43 | -26.81 | -34.69 | 69.23 | 66.99 | -21.29 | -39.40 | 1.24 | -1.86 | 0.941 | -- | 26.81 | 40.07 | 13.14 | -- | 48.19 | -- |
| Establishment Labs Holdings Inc | 190.97m | -82.98m | 2.02bn | 1.02k | -- | 123.43 | -- | 10.58 | -2.84 | -2.84 | 6.53 | 0.5632 | 0.6145 | 0.769 | 2.75 | 187,596.30 | -26.70 | -31.53 | -33.25 | -39.32 | 68.74 | 65.46 | -43.45 | -45.09 | 2.10 | -1.72 | 0.9377 | -- | 0.5292 | 13.14 | -7.76 | -- | 17.33 | -- |
| UFP Technologies Inc | 597.95m | 67.12m | 2.05bn | 4.15k | 30.82 | 5.07 | 23.82 | 3.42 | 8.61 | 8.61 | 76.71 | 52.37 | 0.9261 | 4.89 | 6.86 | 144,223.80 | 10.40 | 10.12 | 11.87 | 11.53 | 28.51 | 27.07 | 11.23 | 10.64 | 1.36 | 8.39 | 0.2657 | 0.00 | 26.08 | 20.52 | 31.29 | 24.46 | 10.82 | -- |
| Neogen Corp | 880.32m | -602.74m | 2.31bn | 2.97k | -- | 1.10 | -- | 2.62 | -2.78 | -2.78 | 4.05 | 9.67 | 0.2375 | 2.63 | 5.95 | 296,005.00 | -16.26 | -7.73 | -16.94 | -8.06 | 45.98 | 48.10 | -68.47 | -27.91 | 2.80 | -0.2109 | 0.2737 | -- | -3.20 | 16.43 | -11,491.59 | -- | 34.18 | -- |
| 10X Genomics Inc | 641.81m | -76.32m | 2.35bn | 1.31k | -- | 2.99 | -- | 3.66 | -0.6249 | -0.6249 | 5.19 | 6.20 | 0.6532 | 2.56 | 10.08 | 491,434.90 | -7.77 | -25.61 | -9.00 | -29.19 | 68.90 | 74.03 | -11.89 | -47.52 | 4.06 | -- | 0.00 | -- | -1.28 | 19.96 | 28.41 | -- | -20.72 | -- |
| Heartflow Inc | -100.00bn | -100.00bn | 2.49bn | 699.00 | -- | 9.60 | -- | -- | -- | -- | -- | 3.05 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | 44.32 | -- | 22.04 | -- | -- | -- |
Data as of Feb 10 2026. Currency figures normalised to Alphatec Holdings Inc's reporting currency: US Dollar USD
26.93%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2025 | 8.58m | 5.78% |
| American Century Investment Management, Inc.as of 30 Sep 2025 | 6.34m | 4.27% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 5.95m | 4.00% |
| BNP Paribas Asset Management USA, Inc.as of 30 Sep 2025 | 3.26m | 2.19% |
| Morgan Stanley & Co. LLCas of 30 Sep 2025 | 3.13m | 2.11% |
| RBC Global Asset Management, Inc.as of 30 Sep 2025 | 2.93m | 1.97% |
| Geode Capital Management LLCas of 30 Sep 2025 | 2.80m | 1.88% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 2.71m | 1.83% |
| Next Century Growth Investors LLCas of 30 Sep 2025 | 2.28m | 1.53% |
| Managed Account Advisors LLCas of 30 Sep 2025 | 2.04m | 1.37% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
